• Light-Inducible RNA Switches Enable Precision Gene Therapy C

  2026-05-07

  A rationally designed light-inducible RNA-releasing protein (LIRP) enables optogenetic, translational-level regulation of therapeutic gene expression in vivo, offering tissue-specific and temporally controlled interventions. This technology advances the safety and flexibility of gene therapies targeting chronic metabolic and retinal diseases.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-06

  The AO/PI Double Staining Kit enables researchers to distinguish viable, apoptotic, and necrotic cells in a single assay using dual fluorescent dyes. This product is suited for rapid, reproducible cell viability, apoptosis, and necrosis detection in a range of cell biology experiments, but is not appropriate for applications requiring live-cell imaging beyond brief exposure or multiplexed staining outside AO/PI channels.

• ATRX-Deficient Glioma Sensitivity to RTK/PDGFR Inhibitors: I

  2026-05-06

  This study identifies that ATRX-deficient high-grade glioma cells are significantly more sensitive to multi-targeted receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. The findings suggest that ATRX mutation status should be considered in clinical trial design and therapeutic strategies for aggressive gliomas.

• Partial β-Secretase Inhibition Preserves Synaptic Function i

  2026-05-05

  Satir et al. (2020) demonstrate that reducing amyloid β (Aβ) production by up to 50% through partial β-secretase (BACE) inhibition does not impair synaptic transmission in primary cortical neurons. These findings support more nuanced therapeutic approaches in Alzheimer's disease, emphasizing moderate BACE inhibition to minimize adverse effects on neuronal function.

• PD0325901 MEK Inhibitor: Optimizing Cancer and Stem Cell Ass

  2026-05-05

  PD0325901, a selective MEK inhibitor supplied by APExBIO, empowers researchers to dissect RAS/RAF/MEK/ERK pathway dynamics with precision in both cancer and stem cell contexts. This guide translates recent mechanistic insights into actionable protocols, troubleshooting tips, and advanced applications for translational research.

• AT13387: Optimizing Hsp90 Inhibitor Workflows in Cancer Biol

  2026-05-04

  AT13387 stands out among Hsp90 inhibitors for its nanomolar potency, unique scaffold, and tumor-selective retention. This guide delivers actionable workflows, troubleshooting tips, and cross-domain insights to empower advanced cancer biology research with precise apoptosis and cell cycle arrest assays.

• Z-DEVD-FMK: Applied Caspase-3 Inhibitor Workflows in Apoptos

  2026-05-04

  Z-DEVD-FMK empowers researchers to dissect caspase-dependent apoptosis and neuroprotection with precision, thanks to its dual inhibition of caspase and calpain pathways. This article translates recent mechanistic insights and in vivo findings into actionable, optimized workflows for cancer and neuronal injury models.

• VX-661: Precision Rescue of F508del CFTR—Systems Biology to

  2026-05-03

  Explore VX-661, a leading F508del CFTR corrector, through the lens of systems-level protein folding and calnexin-driven rescue. This article offers advanced insights and actionable guidance for cystic fibrosis research, grounded in the latest mechanistic discoveries.

• γH2AX DNA Damage Detection Kit: Precision DSB Biomarker in A

  2026-05-02

  The γH2AX DNA Damage Detection Kit (Mouse mAb/Red) from APExBIO empowers researchers to sensitively quantify DNA double-strand breaks and repair kinetics in complex experimental systems. Its robust immunofluorescence workflow and validated antibody specificity enable high-content genotoxicity, apoptosis, and DNA repair studies, even in challenging contexts like radioimmunotherapy and nanoparticle radiosensitization.

• Targeting GOT1 for Metabolic Disruption in Pancreatic Cancer

  2026-05-02

  This study identifies ziprasidone as a novel non-competitive inhibitor of GOT1, disrupting glutamine metabolism and redox balance in pancreatic ductal adenocarcinoma (PDAC) cells. The findings provide mechanistic insight into metabolic vulnerabilities in PDAC and highlight GOT1 inhibition as a promising therapeutic strategy.

• PTX3-TLR4/NF-κB-FGF21 Axis in Glucocorticoid-Induced ONFH

  2026-05-01

  This study uncovers a protective mechanism in glucocorticoid-induced osteonecrosis of the femoral head (ONFH), identifying PTX3 as a modulator of the TLR4/NF-κB/FGF21 signaling axis. The findings reveal potential therapeutic targets and inform future osteoclastogenesis research and intervention strategies.

• JNJ-26481585 (Quisinostat): Applied Workflows for Tumor Assa

  2026-04-30

  JNJ-26481585 (Quisinostat) empowers cancer researchers to dissect epigenetic modulation, induce apoptosis, and overcome drug resistance in advanced tumor models. This guide details robust experimental workflows, actionable protocol parameters, and troubleshooting strategies, all underpinned by the latest TRIM21–ERK1/2 research and APExBIO’s trusted supply chain.

• Advancing Mammalian Cell Viability: Insights with Calcein AM

  2026-04-30

  Explore how the Live-Dead Cell Staining Kit I (Calcein AM/PI) delivers rigorous, real-time assessment of mammalian cell viability and cytotoxicity. This article uniquely bridges advanced assay science with translational research, offering deep protocol and mechanistic guidance.

• EdU Imaging Kits (HF594): Technical Guide for Proliferation

  2026-04-29

  EdU Imaging Kits (HF594) enable direct, sensitive detection of DNA synthesis as a measure of cell proliferation, streamlining workflows that previously relied on more disruptive methods. Recommended for applications in cell proliferation assays by fluorescence microscopy or flow cytometry, these kits should not be used where antibody-based detection or native DNA structure is required. Not suitable for live-cell tracking or when copper-free environments are essential.

• Protein A/G Magnetic Beads: Protocol and QC for Antibody Cap

  2026-04-29

  Protein A/G Magnetic Beads provide a reproducible tool for capturing and purifying IgG antibodies from complex biological samples, including serum and cell culture supernatants. They are best used in immunoprecipitation, co-immunoprecipitation, and chromatin IP workflows where specificity and low background are critical. Not suitable for diagnostic or medical applications, and should not be substituted for beads designed for non-IgG isotypes.

16260 records 1/1084 page Next 12345 下5页 Last page